The federal contract IDV is a multiple-award Federal Supply Schedule contract with the Department of Veterans Affairs (VA) for the procurement of pharmaceutical products, medical supplies, and vaccines. The contract has a total ceiling value of $3.9 billion and a period of performance through July 31, 2027. The prime contractor is Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company that provides a range of medical products to various federal agencies. Under this IDV, Glaxosmithkline has been awarded several delivery orders to supply influenza vaccines, antiviral medications, and other pharmaceutical goods to agencies such as the Department of State, Federal Bureau of Investigation, Department of the Army, and VA. The delivery orders are primarily firm fixed-price contracts, with values ranging from $29,768 to $8.7 million. The products are delivered to locations across the United States, supporting federal immunization programs, disease prevention efforts, and pharmaceutical stockpiling for emergency preparedness. Glaxosmithkline also holds a single-award Blanket Purchase Agreement with the VA National Acquisition Center for the procurement of the pharmaceutical product FLOLAN, valued up to $299,605 over 3 years.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00060 | Supplemental Agreement for work within scope | $0 | 6/2/25 | |
| P00059 | Supplemental Agreement for work within scope | $0 | 4/11/25 | |
| P00058 | Supplemental Agreement for work within scope | $0 | 3/27/25 | |
| P00057 | Supplemental Agreement for work within scope | $0 | 3/11/25 | |
| P00056 | Add Subcontract Plan | $0 | 3/10/25 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Last Date To Order (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
36F79722D0178-36E79722A0024 | Glaxosmithkline, LLC | $299.6k | 9/1/22 | 8/31/26 | 7/10/25 |
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79722D0178-36C26124N0568 | Glaxosmithkline, LLC | $80.3k | 4/9/24 | 10/15/24 | 4/9/24 | |
Delivery Order 36F79722D0178-75A50323F80021 | Glaxosmithkline, LLC | $8.7m | 8/17/23 | 8/29/24 | 10/18/23 | |
Delivery Order 36F79722D0178-W901UZ22F0064 | Glaxosmithkline, LLC | $34.6k | 8/17/22 | 9/14/22 | 8/17/22 | |
Delivery Order 36F79722D0178-19AQMM22F4148 | Glaxosmithkline, LLC | $634.1k | 9/23/22 | 10/6/22 | 7/24/24 | |
Delivery Order 36F79722D0178-W912L723F0017 | Glaxosmithkline, LLC | $29.8k | 6/2/23 | 6/17/23 | 6/2/23 |